Literature DB >> 6129441

Treatment of diffuse cutaneous leishmaniasis with chlorpromazine ointment.

T H Henriksen, S Lende.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6129441     DOI： 10.1016/s0140-6736(83)91769-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Authors:  Shyam Sundar; Neha Agrawal; Bhawana Singh
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-17       Impact factor: 4.481

2.  Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride.

Authors:  J el-On; L Weinrauch; R Livshin; Z Even-Paz; G P Jacobs
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-14

3.  Cutaneous leishmaniasis: failure of topical treatment with imidazole derivatives in laboratory animals and man.

Authors:  L Weinrauch; R Livshin; G P Jacobs; J El-On
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

4.  Antileishmanial activity of chlorpromazine.

Authors:  R D Pearson; A A Manian; D Hall; J L Harcus; E L Hewlett
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

Review 5.  Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review.

Authors:  Johan van Griensven; Endalamaw Gadisa; Abraham Aseffa; Asrat Hailu; Abate Mulugeta Beshah; Ermias Diro
Journal:  PLoS Negl Trop Dis       Date:  2016-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.